MedeAnalytics Celebrates 25 Years of Helping Healthcare Make Even Smarter Decisions

This week, MedeAnalytics celebrates our 25th anniversary! Mede has evolved significantly since its revenue cycle beginnings, and through it all, our dedication to helping improve the business of healthcare through smarter decision making has never wavered.

Founded in 1993, MedeAnalytics was the first to go to market with an analytics SaaS solution built specifically for healthcare. We applied that same innovative spirit to expand into the payer market in 2007 and into the public sector in 2016. In 2013 when the needs of payers and providers began to converge, our experience with stakeholders across the healthcare continuum enabled us to create solutions that address ACOs, population health, and new risk arrangements.

Our proudest moments throughout these 25 years include the tangible ways in which we add value to our clients:

  • Expanding our health system solutions beyond RCM analytics to include cost and operations, value-based performance management, and enterprise performance management
  • Launching our Payer Innovation Exchange to harness the power of our client network to guide our innovation roadmap
  • Reaching 60 million covered lives within our healthcare analytics platform
  • Surpassing 1,500 payers and providers who partner with us in improving healthcare with data analytics

Of course, we wouldn’t have made it this far without our valued clients. It’s their need for quality analytics capabilities that keeps us motivated every day. They challenge us to consistently improve so we can continue to help them achieve diverse business goals. When our clients interact with their account representatives, implement a new solution, or participate in our events, we expect that our devotion to excellence in every experience will be evident.

We thank our clients for their dedication to MedeAnalytics and for joining us in our mission to improve healthcare. We look forward to another 25 years of partnership.

Paul Kaiser
CEO, MedeAnalytics

Posted in

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

How to help employer groups plan in a time of uncertainty

June 15, 2020

Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”

Read on...

Healthcare’s return to “normal” after COVID-19: Is it possible?

June 9, 2020

As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”

Read on...

Avoid COVID-19 modeling pitfalls by eliminating bias, using good data

June 2, 2020

COVID-19 models are being used every day to predict the course and short- and long-term impacts of the pandemic. And we’ll be using these COVID-19 models for months to come.

Read on...

Population Health Amid the Coronavirus Outbreak

May 19, 2020

In speaking with many colleagues throughout the provider and payer healthcare community, I’ve found an overwhelming sense of helplessness to the outbreak’s onslaught. This is exacerbated by the constant evolution of reported underlying medical conditions that indicate a higher risk of hospitalization or mortality for a coronavirus patient.

Read on...